Clinical trial
S9624 Ifosfamide in Treating Patients With Meningeal Tumors
NCT00003292 · SWOG Cancer Research Network, Other · Terminated
Key facts
| NCT number | NCT00003292 |
|---|---|
| Title | S9624 Ifosfamide in Treating Patients With Meningeal Tumors |
| Official title | S9624: Phase II Study of Ifosfamide in Patients With Aggressive Meningeal Tumors |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH Eastern Cooperative Oncology Group |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chondrosarcoma, Adult Fibrosarcoma, Adult Leiomyosarcoma, Adult Rhabdomyosarcoma, Adult Malignant Meningioma, Adult Brain Malignant Hemangiopericytoma |
| Intervention type | Drug |
| Interventions | ifosfamide |
| Enrollment | 7 |
| Start date | Jul 1, 1998 |
| Primary completion | Jan 1, 2004 |
| Completion | Jan 1, 2004 |
| First posted | Jan 27, 2003 |
| Last update posted | Nov 8, 2013 |
| Countries | Australia, Peru, Puerto Rico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: